CardioWise

Fayetteville, AR · Founded 2010 · Privately Held (backing)

Developer of a non-invasive cardiac CT imaging software designed for speedy quantitative analysis of left ventricular function. CardioWise is based in Fayetteville, AR and was founded in 2010. It was valued at $33 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $5.7 million across 4 recorded rounds; the latest was a $300,000 debt round in Nov 2021.

PMV mark · valuation
$33.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$5.7M
Last round
Debt
Nov 2021
What is CardioWise worth?
$33.0MPrivateMarketView mark · Oct 2026

Valued at $33.0M at its later-stage round, Jul 2025. Nothing has traded since.

Free account
More of CardioWise with a free account
  • ·Watch CardioWise: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

CardioWise funding history

4 rounds
DateRoundRaisedPost-money
Nov 2021Debt$300K▮
Mar 2020Seed Round$340K▮
Feb 2018Debt$357K▮
Mar 2014Seed Round$620K▮
Unlock post-money valuations

Membership and data by Private Market View

CardioWise valuation

CardioWise was valued at $33 million at its later-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has CardioWise raised?

CardioWise has raised $5.7 million in total; 4 of its rounds are on record, from 2014 on. The largest on record was a $620,000 seed round in Mar 2014; the most recent was a $300,000 debt round in Nov 2021.

CardioWise has filed 8 Form Ds with the SEC since 2012, most recently in Sep 2025 (null sold).

How CardioWise's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For CardioWise, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about CardioWise

What is CardioWise worth?
CardioWise is valued at $33.0M as of Oct 2026. Valued at $33.0M at its later-stage round, Jul 2025. Nothing has traded since.
How much has CardioWise raised?
CardioWise has raised $5.7M in total funding across 4 recorded rounds.
When did CardioWise last raise?
CardioWise last raised in Nov 2021 (Debt), raising $300K.